NKO

Yes: licensed in Canada

The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.

Licence status Active; licensed December 6, 2011; licence last revised March 17, 2023.

Also sold as

Other product names on the same licence.

Per dosage unit, as licensed.

Ingredient	Amount	Source and potency
Krill oil	1,000 milligrams	Euphausia superba - Whole; 300 milligrams Omega-3 fatty acids
Krill oil	—	Euphausia superba - Whole; 150 milligrams Eicosapentaenoic acid
Krill oil	—	Euphausia superba - Whole; 90 milligrams Docosahexaenoic acid
Krill oil	—	Euphausia superba - Whole; 420 milligrams Phospholipids
Krill oil	—	Euphausia superba - Whole; 1 milligrams Esterified astaxanthin

The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.

1- Source of omega-3 fatty acids for the maintenance of good health. 2- Source of EPA and DHA for the maintenance of good health. 3- Helps to relieve symptoms of dysmenorrhea and premenstrual syndrome. 4- Helps to relieve symptoms of premenstrual syndrome. 5- Helps to maintain cardiovascular health. 6- In conjunction with conventional statin therapy, helps to reduce serum triglycerides/triacylglycerols. 7- In conjunction with conventional statin therapy, helps to reduce the levels of LDL cholesterol. 8- In conjunction with conventional statin therapy, helps to increase the levels of HDL cholesterol. 9- Helps to support/maintain eye health/function. 10- Helps to support/maintain visual health/function. 11- Helps to support/maintain normal brain function. Source of antioxidant(s)/Provides antioxidant(s) Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals

Purified water; Gelatin; Sorbitol; Glycerol; Ethyl Vanillin